Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.
Researchers have developed an inhalable nanoparticle system for delivering rifampin directly to the lungs, potentially reducing tuberculosis treatment from daily to once-weekly dosing while lowering side effects and improving drug effectiveness.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07341100 |
Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC |
ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05250050 |
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment |
WITHDRAWN | PHASE4 |
| NCT04026958 |
Clarithromycin Mechanisms in Hypersomnia Syndromes |
COMPLETED | PHASE2 |
| NCT02343042 |
Selinexor and Backbone Treatments of Multiple Myeloma Patients |
RECRUITING | PHASE1/PHASE2 |
| NCT01559935 |
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma |
COMPLETED | PHASE2 |
